$4.18
-0.11-2.56%
Last update: Oct 8, 4:15 PM
$4.07
-0.22-5.13%
Arbutus Biopharma Corp
ABUSNASDAQ
Wall Street analyst price targets and consensus rating for Arbutus Biopharma (ABUS).
Price Target Range — 7 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
